Response to taxanes in triple negative breast cancer

被引：0
|
作者：
Nilufer Bulut
Sadettin Kilickap
Ebru Sari
Kadri Altundag
机构：
[1] Hacettepe University,Department of Medical Oncology, Institute of Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 63卷
关键词：
Breast Cancer; Paclitaxel; Doxorubicin; Taxanes; Triple Negative Breast Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：189 / 189
相关论文
共 50 条
  • [1] Response to taxanes in triple negative breast cancer
    Bulut, Nilufer
    Kilickap, Sadettin
    Sari, Ebru
    Altundag, Kadri
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 63 (01) : 189 - 189
  • [2] CLINICAL RESPONSE OF TRIPLE NEGATIVE BREAST CANCER TO TAXANES
    Saito, K.
    Mizuno, T.
    Taniguchi, M.
    Yamashita, Y.
    Yamamura, K.
    Tamaru, S.
    Kageyama, S.
    Katayama, N.
    ANNALS OF ONCOLOGY, 2010, 21 : 91 - 91
  • [3] Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Jiannan Wu
    Shunrong Li
    Weijuan Jia
    Fengxi Su
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1505 - 1510
  • [4] Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Wu, Jiannan
    Li, Shunrong
    Jia, Weijuan
    Su, Fengxi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (10) : 1505 - 1510
  • [5] The role of taxanes in triple-negative breast cancer: literature review
    Mustacchi, Giorgio
    De Laurentiis, Michelino
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 4303 - 4318
  • [6] Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer
    Sakuma, Kaori
    Kurosumi, Masafumi
    Oba, Hanako
    Kobayashi, Yasuhito
    Takei, Hiroyuki
    Inoue, Kenichi
    Tabei, Toshio
    Oyama, Tetsunari
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (02) : 257 - 264
  • [7] A CASE REPORT ON NEUTROPENIC ENTEROCOLITIS IN A PATIENT WITH TRIPLE-NEGATIVE BREAST CANCER TREATED WITH TAXANES
    Mandal, Shobha
    Jagan, Suchetha
    Priyadarshini, Shista
    Jha, Saswat D. R.
    Manas, F. N. U.
    Kakakhel, Zanaib
    CHEST, 2022, 162 (04) : 727A - 727A
  • [8] Response to Neoadjuvant Chemotherapy of Triple Negative Breast Cancer
    Tokudome, N.
    Ito, Y.
    Takahashi, S.
    Sugihara, T.
    Hosonaga, M.
    Iwasaki, R.
    Hattori, M.
    Fukuda, T.
    Mitsuhashi, K.
    Kobayashi, K.
    Taira, S.
    Saito, Y.
    Fukada, I
    Ueki, N.
    Tsutsumi, C.
    Miyagi, Y.
    Iwase, T.
    Osako, T.
    Horii, R.
    Akiyama, F.
    Hatake, K.
    CANCER RESEARCH, 2009, 69 (24) : 571S - 572S
  • [9] Predictors of Immunotherapy Response in Triple Negative Breast Cancer
    Yiduo Hu
    Rachel Yoder
    Priyanka Sharma
    Current Breast Cancer Reports, 2025, 17 (1)
  • [10] Predicting the response of triple negative breast cancer to doxorubicin
    McKenna, Matthew T.
    Barnes, Stephanie L.
    Weis, Jared A.
    Searfoss, Abigail M.
    Tyson, Darren R.
    Rericha, Erin C.
    Miga, Michael I.
    Quaranta, Vito
    Yankeelov, Thomas E.
    CANCER RESEARCH, 2017, 77
12345